Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017; New Report Launched
Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017 report provides an overview of the pipeline landscape for genetic ophthalmological disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Stargardt disease, Leber congenital amaurosis, Leber's hereditary optic neuropathy, Usher Syndrome and Retinitis pigmentosa, and features dormant and discontinued projects.
View full press release